Enzastaurin in Combination of Capecitabine to Treat Breast Cancer
Clinical trial NCT00437294 · TERMINATED
Trial details
- NCT number
- NCT00437294
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2009-03-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.